Ginecología

Question 1

Mammographic finding associated with decreased screening sensitivity and increased risk for breast cancer

ACP August 2024

Answer 1

Dense breast tissue

Question 2

Class of drugs indicated for initial nonhormonal analgesic treatment for dysmenorrhea

ACP August 2024

Answer 2

NSAIDs (also accept cyclooxygenase-2 inhibitors)

Question 3

Human papilloma virus type most highly associated with invasive cervical cancer

ACP August 2024

Answer 3

16

Question 4

T-cell lymphoma associated with textured breast implants

ACP August 2024

Answer 4

Anaplastic large cell lymphoma (accept ALCL; ask for more specific detail if answer given is T-cell lymphoma)

Question 5

Diagnosis associated with clue cells

ACP August 2024

Answer 5

Bacterial vaginosis

Question 6

Most common female sexual disorder

ACP January 2019

Answer 6

Hypoactive sexual desire disorder

Question 7

FDA approved androgen drug for severe mastalgia

ACP january 2019

Answer 7

Danazol

Question 8

Contraceptive class associated with prolonged infertility after discontinuation

ACP January 2019

Answer 8

Long acting progesterone (accept specific examples; long-acting progesterone injection, implants, or IUD)

Question 9

Period of time after intercourse levonorgestrel is effective in preventing pregnancy

ACP January 2019

Answer 9

5 days (120 hours)

Question 10

When indicated, timing of Tdap during pregnancy

ACP January 2019

Answer 10

Between 20 weeks and delivery (accept after 20 weeks; do not accept after delivery)

Question 11

Preferred drug for Trichomonas vaginitis during pregnancy

ACP october 2019

Answer 11

Metronidazole

Question 12

Vulvar lichen sclerosus predisposes to this condition

ACP october 2019

Answer 12

Vulvar squamous cell carcinoma

Question 13

Primary sexual function disorder characterized by a lack of sexual interest or arousal for at least 6 months that causes personal distress

ACP october 2019

Answer 13

Sexual interest/arousal disorder

Question 14

Older term for female pattern hair loss

ACP october 2019

Answer 14

Androgenic alopecia

Question 15

Vaccine administered to women between 27 and 36 weeks’ gestation in all pregnancies

ACP october 2019

Answer 15

Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine

Question 16

Most common female sexual disorder

ACP December 2016

Answer 16

Hypoactive sexual desire disorder

Question 17

FDA approved androgen drug for severe mastalgia

ACP December 2016

Answer 17

Danazol

Question 18

Contraceptive class associated with prolonged infertility after discontinuation

ACP December 2016

Answer 18

Long acting progesterone (accept specific examples; long-acting progesterone injection, implants, or IUD)

Question 19

Period of time after intercourse levonorgestrel is effective in preventing pregnancy

ACP December 2016

Answer 19

5 days (120 hours)

Question 20

When indicated, timing of Tdap during pregnancy

ACP December 2016

Answer 20

Between 20 weeks and delivery (accept after 20 weeks; do not accept after delivery)

Question 21

Agent needed to conduct the ‘whiff test’ for bacterial vaginosis

ACP December 2024

Answer 21

10% potassium hydroxide (accept potassium hydroxide and accept KOH)

Question 22

Breast mass imaging modality for women younger than 30 years of age or who are pregnant

ACP December 2024

Answer 22

Ultrasonography

Question 23

Activity associated with decreased risk of breast, ovarian, and endometrial cancer

ACP December 2024

Answer 23

Breastfeeding

Question 24

pH associated with vaginal atrophy

ACP December 2024

Answer 24

≥5

Question 25

Most effective non-hormonal medication class for treatment of moderate-to-severe premenstrual dysphoric disorder ## Footnote ACP December 2024

Answer 25

Selective serotonin reuptake inhibitors (accept SSRIs)

Question 26

Leading cause of death from gynecologic malignancy in the United States ## Footnote ACP August 2018

Answer 26

Ovarian cancer

Question 27

Syndrome name for the most common form of gonadal dysgenesis ## Footnote ACP August 2018

Answer 27

Turner syndrome

Question 28

Selective receptor estrogen modulator approved for the treatment of vulvovaginal atrophy ## Footnote ACP August 2018

Answer 28

Ospemifene

Question 29

Vulvar lichen sclerosis predisposes to this condition ## Footnote ACP August 2018

Answer 29

Vulvar squamous cell carcinoma

Question 30

Chronic vulvar discomfort occurring in the absence of visible findings or clinically identifiable disorder ## Footnote ACP August 2018

Answer 30

Vulvodynia

Question 31

Most common pituitary cause of secondary amenorrhea ## Footnote ACP April 2022

Answer 31

Prolactinoma

Question 32

Common benign mass at the vaginal introitus ## Footnote ACP April 2022

Answer 32

Bartholin cyst

Question 33

Most common cause of secondary amenorrhea in women with an intact uterus ## Footnote ACP April 2022

Answer 33

Uterine scarring (accept Asherman syndrome or intrauterine adhesions)

Question 34

Two most common causes of hyperthyroidism during pregnancy ## Footnote ACP April 2022

Answer 34

Graves disease and human chorionic gonadotropin (hCG)-mediated hyperthyroidism (require both)

Question 35

This lesion predisposes to vulvar squamous cell carcinoma ## Footnote ACP April 2022

Answer 35

Vulval lichen sclerosis (accept lichen sclerosis; cervical intraepithelial neoplasia)

Question 36

Supplement indicated for all women capable of becoming pregnant ## Footnote ACP May 2022

Answer 36

Folate

Question 37

Chronic anovulation results in this endometrial change ## Footnote ACP May 2022

Answer 37

Hyperplasia or malignancy (accept either)

Question 38

Bleeding disorder most commonly associated with menorrhagia ## Footnote ACP May 2022

Answer 38

von Willebrand disease

Question 39

Most appropriate blood test for a woman with headache, oligomenorrhea and galactorrhea ## Footnote ACP May 2022

Answer 39

Prolactin level

Question 40

Drug treatment of transient diabetes insipidus of pregnancy ## Footnote ACP May 2022

Answer 40

Desmopressin

Question 41

Diagnosis confirmed by presence of these cells | Falta Imagen

Answer 41

Bacterial vaginosis

Question 42

Clotting disorder characteristically associated with menorrhagia ## Footnote ACP May 2013

Answer 42

von Willebrand disease

Question 43

Finding in this wet mount | Falta Imagen ## Footnote ACP May 2013

Answer 43

Trichomonads (accept trichomoniasis)

Question 44

Mineral supplement that reduces PMS symptoms ## Footnote ACP May 2013

Answer 44

Calcium

Question 45

Eponym for an erythematous vulvar plaque that has a cancer association ## Footnote ACP May 2013

Answer 45

Extramammary Paget disease (accept Paget disease)